Tamoxifen, a selective estrogen receptor modulator, with proven effects inreducing mortality and relapse rates in patients with breast cancer, did notinterfere with the number of oocytes retrieved during controlled ovarianstimulation (Meirow et al.,2014). The gene discussed is ESR1; the disease is breast cancer.